Insider · CIK 0001824711
Quan Lucinda Y.
Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA
Transactions
12
Companies
1
Filings
6
CIK
0001824711
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-09-08 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-03-15 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-07-07 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-02-04 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-02-04 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-12-01 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-10-20 | ALGSAligos Therapeutics, Inc.C Conversion | — |
| 2020-10-20 | ALGSAligos Therapeutics, Inc.C Conversion | — |
| 2020-10-20 | ALGSAligos Therapeutics, Inc.C Conversion | — |
| 2020-10-20 | ALGSAligos Therapeutics, Inc. · Series A Preferred StockC Conversion | — |
| 2020-10-20 | ALGSAligos Therapeutics, Inc. · Series B-1 Preferred StockC Conversion | — |
| 2020-10-20 | ALGSAligos Therapeutics, Inc. · Series B-2 Preferred StockC Conversion | — |
Recent filings
- 4Quan Lucinda Y.0001610717-23-000275SEC(opens sec.gov)
- 4Quan Lucinda Y.0001567619-23-005254SEC(opens sec.gov)
- 4Quan Lucinda Y.0001567619-22-013869SEC(opens sec.gov)
- 4Quan Lucinda Y.0001567619-22-002890SEC(opens sec.gov)
- 4Quan Lucinda Y.0001567619-20-020623SEC(opens sec.gov)
- 4Quan Lucinda Y.0001567619-20-018004SEC(opens sec.gov)
Companies
Address
C/O ALIGOS THERAPEUTICS, INC. 1 CORPORATE DRIVE, 2ND FLOOR
SOUTH SAN FRANCISCO, CA, 94080